Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for Cannabis Withdrawal
NCT02083874Phase 2Unknown
- Sponsor
- University of New South Wales
- Start
- Mar 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of cannabidiol in cannabis withdrawal, sponsored by University of New South Wales. Primary endpoints: Severity of cannabis withdrawal at 7 days and Safety of CBD for cannabis withdrawal at 7 days. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
cannabis withdrawal
Beyond the preview
Go deeper on NCT02083874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083874.